Skip NavigationSkip to Content

CBL Newsroom

January 2018
Dr. Scott Walsh
NCI Director’s Innovation Award

Dr. Scott Walsh, a Staff Scientist in the Schneider lab, has been awarded a 2018 Director's Intramural Innovation Award for his proposal entitled "Rebuilding T cells for Cancer Immunodeficiencies using the IL-7 Pathway". This research is a collaboration with Dr. Scott Durum from the Cancer and Inflammation Program. The NCI Director’s Intramural Innovation Award Program is designed to support the development of highly innovative approaches and technology aimed at significant cancer-related problems. Novel proposals with the potential for high impact, the potential to generate new intellectual property or technology, or which are considered too high-risk or preliminary to pursue within the base budget allocation are encouraged, as are proposals with an emphasis on health disparities research.